Aesica appoints VP, Business Development and Business Development Director for Finished Dose Aesica appoints VP, Business Development and Business Development Director for Finished Dose To drive service in Europe and achieve further growth Steven Fasman joins Catalent as SVP and General Counsel Steven Fasman joins Catalent as SVP and General Counsel With extensive legal experience across a broad range of industries Mark Griffiths joins board of Dishman Pharmaceuticals and Chemicals Mark Griffiths joins board of Dishman Pharmaceuticals and Chemicals He has been Chief Executive of Dishman and Carbogen Amcis for three years Aptuit appoints Operations and General Manager in Verona, Italy Aptuit appoints Operations and General Manager in Verona, Italy Manuela Leone will oversee Aptuit’s drug discovery and development operations West promotes Karen Flynn to President of Pharmaceutical Packaging Systems West promotes Karen Flynn to President of Pharmaceutical Packaging Systems She brings more than 28 years of experience to the role Kathleen Glaub joins Codexis board Kathleen Glaub joins Codexis board Brings 30 years of drug development experience to the position New Chair and Deputy Chair elected to ECHA Management Board New Chair and Deputy Chair elected to ECHA Management Board Nina Cromnier has been re-elected as Chair while Karel Blaha becomes the new Deputy Chair ADC Therapeutics adds eight new members of staff ADC Therapeutics adds eight new members of staff As the company continues to expand its pipeline of antibody drug conjugates Nanobiotix expands operations into the US Nanobiotix expands operations into the US Senior pharmaceutical executive appointed as Vice President of Corporate Development Kevin Williams joins Lonza as Senior Scientist, Endotoxin Detection Kevin Williams joins Lonza as Senior Scientist, Endotoxin Detection He has more than 30 years of hands-on experience in pharmaceutical quality control Pistoia Alliance appoints Business Development Director North America Pistoia Alliance appoints Business Development Director North America Organisation looks to expand its global reach New recruits bring two decades of compliance and data management experience to Veeva Europe New recruits bring two decades of compliance and data management experience to Veeva Europe Guillaume Roussel and Francesca D’Angelo join the company Catalent makes two promotions Catalent makes two promotions To support drug development and clinical trial growth in the US, Europe and Asia Array BioPharma appoints Victor Sandor as Chief Medical Officer Array BioPharma appoints Victor Sandor as Chief Medical Officer Clinical oncology expert joins as the company advances its late-stage clinical programmes Dr Thomas Colacot wins 2015 ACS Industrial Chemistry Award Dr Thomas Colacot wins 2015 ACS Industrial Chemistry Award In recognition of his contribution to the area of catalysis Almac appoints two marketing directors Almac appoints two marketing directors Matt Cocking and Laura Montgomery join the Irish CDMO Jarrod Longcor joins Avillion as Chief Business Officer Jarrod Longcor joins Avillion as Chief Business Officer Will take responsibility for negotiating co-development agreements and financial investments TiGenix makes two appointments TiGenix makes two appointments A new Chief Medical Officer and VP of Medical Affairs and New Product Commercialisation join the company Drew Young joins EMD Serono as Senior Vice President, Neurology and Immunology Drew Young joins EMD Serono as Senior Vice President, Neurology and Immunology Joins the US biopharmaceutical company from Biogen Idec Alexander Karle becomes CEO of Evaluate Alexander Karle becomes CEO of Evaluate Founder Jonathan de Pass to become Chairman Vifor Pharma appoints heads of International Business Operations and Global Marketing Vifor Pharma appoints heads of International Business Operations and Global Marketing They will be based at company headquarters in Zurich, Switzerland Nabriva Therapeutics hires Colin Broom as CEO Nabriva Therapeutics hires Colin Broom as CEO Also establishes new US subsidiary in the Philadelphia area Merck makes two management changes Merck makes two management changes To take effect on 1 January 2015 Novimmune appoints Adrian Mills as Chief Business Officer Novimmune appoints Adrian Mills as Chief Business Officer Also becomes a member of the Executive Committee